Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction

Hepatocyte growth factor (HGF) has been shown to have anti-fibrotic, pro-angiogenic, and cardioprotective effects; however, it is highly unstable and expensive to manufacture, hindering its clinical translation. Recently, a HGF fragment (HGF-f), an alternative c-MET agonist, was engineered to posses...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Biomaterials
Main Authors: Sonnenberg, Sonya, Rane, Aboli A., Liu, Cassie J., Rao, Nikhil, Agmon, Gillie, Suarez, Sophia, Wang, Raymond, Munoz, Adam, Bajaj, Vaibhav, Zhang, Shirley, Braden, Rebecca, Schup-Magoffin, Pamela J., Kwan, Oi Ling, DeMaria, Anthony N., Cochran, Jennifer R., Christman, Karen L.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2015
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4326250/
https://ncbi.nlm.nih.gov/pubmed/25662495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2014.12.021
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים